PortfoliosLab logoPortfoliosLab logo
COGT vs. ^GSPC
Performance
Return for Risk
Drawdowns
Volatility

Performance

COGT vs. ^GSPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cogent Biosciences, Inc. (COGT) and S&P 500 Index (^GSPC). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

COGT vs. ^GSPC - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
COGT
Cogent Biosciences, Inc.
-0.79%355.38%32.65%-49.13%34.73%-23.60%289.93%-83.64%-60.40%
^GSPC
S&P 500 Index
-3.95%16.39%23.31%24.23%-19.44%26.89%16.26%28.88%-5.07%

Returns By Period

In the year-to-date period, COGT achieves a -0.79% return, which is significantly higher than ^GSPC's -3.95% return.


COGT

1D
-8.44%
1M
-9.39%
YTD
-0.79%
6M
149.40%
1Y
508.64%
3Y*
48.37%
5Y*
31.16%
10Y*

^GSPC

1D
0.72%
1M
-4.45%
YTD
-3.95%
6M
-2.02%
1Y
16.73%
3Y*
16.96%
5Y*
10.34%
10Y*
12.24%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

COGT vs. ^GSPC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COGT
COGT Risk / Return Rank: 9999
Overall Rank
COGT Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
COGT Sortino Ratio Rank: 9999
Sortino Ratio Rank
COGT Omega Ratio Rank: 9898
Omega Ratio Rank
COGT Calmar Ratio Rank: 9999
Calmar Ratio Rank
COGT Martin Ratio Rank: 9999
Martin Ratio Rank

^GSPC
^GSPC Risk / Return Rank: 6767
Overall Rank
^GSPC Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
^GSPC Sortino Ratio Rank: 6464
Sortino Ratio Rank
^GSPC Omega Ratio Rank: 6969
Omega Ratio Rank
^GSPC Calmar Ratio Rank: 6060
Calmar Ratio Rank
^GSPC Martin Ratio Rank: 7777
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COGT vs. ^GSPC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cogent Biosciences, Inc. (COGT) and S&P 500 Index (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


COGT^GSPCDifference

Sharpe ratio

Return per unit of total volatility

3.78

0.92

+2.87

Sortino ratio

Return per unit of downside risk

6.02

1.41

+4.61

Omega ratio

Gain probability vs. loss probability

1.77

1.21

+0.56

Calmar ratio

Return relative to maximum drawdown

15.97

1.41

+14.56

Martin ratio

Return relative to average drawdown

46.51

6.61

+39.89

COGT vs. ^GSPC - Sharpe Ratio Comparison

The current COGT Sharpe Ratio is 3.78, which is higher than the ^GSPC Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of COGT and ^GSPC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


COGT^GSPCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.78

0.92

+2.87

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.33

0.61

-0.29

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.68

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.02

0.46

-0.48

Correlation

The correlation between COGT and ^GSPC is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Drawdowns

COGT vs. ^GSPC - Drawdown Comparison

The maximum COGT drawdown since its inception was -98.09%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for COGT and ^GSPC.


Loading graphics...

Drawdown Indicators


COGT^GSPCDifference

Max Drawdown

Largest peak-to-trough decline

-98.09%

-56.78%

-41.31%

Max Drawdown (1Y)

Largest decline over 1 year

-29.72%

-12.14%

-17.58%

Max Drawdown (5Y)

Largest decline over 5 years

-76.34%

-25.43%

-50.91%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-47.47%

-5.78%

-41.69%

Average Drawdown

Average peak-to-trough decline

-78.47%

-10.75%

-67.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.50%

2.60%

+7.90%

Volatility

COGT vs. ^GSPC - Volatility Comparison

Cogent Biosciences, Inc. (COGT) has a higher volatility of 17.25% compared to S&P 500 Index (^GSPC) at 5.37%. This indicates that COGT's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


COGT^GSPCDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.25%

5.37%

+11.88%

Volatility (6M)

Calculated over the trailing 6-month period

86.50%

9.55%

+76.95%

Volatility (1Y)

Calculated over the trailing 1-year period

135.65%

18.33%

+117.32%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

95.18%

16.90%

+78.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

168.05%

18.05%

+150.00%